Last updated on July 2019

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

Brief description of study

This is a study of experimental medication BMS-986036 given to adults with Nonalcoholic Steatohepatitis (NASH; the buildup of fat and inflammation in the liver that is not caused by alcohol) and stage 3 liver fibrosis (severe fibrosis).

Clinical Study Identifier: NCT03486899

Find a site near you

Start Over

Digestive Disease Associates

Catonsville, MD United States
  Connect »

Mercy Medical Center - McAuley Plaza

Baltimore, MD United States
  Connect »